Avantor, Inc. (AVTR) provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits.
It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.
In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Avantor, Inc. reported 1st Quarter March 2021 earnings of $0.35 per share on revenue of $1.8 billion. The consensus earnings estimate was $0.28 per share on revenue of $1.7 billion. Revenue grew 17.6% on a year-over-year basis.
With an increase of over 370% since March 2020 and with a strong earnings per share, this stock is sure to rise.
We will be trading June 18th Call options
Last Trade: $31.17
Trading Range: $16.37 - $33.99
Trade
Profit/Loss Analysis
Closing Summary
|
|